Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897078 · ClinicalTrials.gov registry record
Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 39
- Enrollment target
NCT00897078 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 39 participants.
The verdict
NCT00897078 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about metabolic syndrome from young patients who have survived acute lymphoblastic leukemia (ALL) may help doctors learn more about the disease. PURPOSE: This phase I trial is studying the metabolic syndrome in young patients who have survived acute lymphoblastic leukemia and in healthy sibling volunteers.
Interventions
- OTHER laboratory biomarker analysis
- OTHER medical chart review
- OTHER questionnaire administration
- PROCEDURE assessment of therapy complications
- OTHER metabolic assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00897078
The ClinicalTrials.gov registry entry for NCT00897078 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT00897078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00897078 about?
NCT00897078 is a clinical study titled "Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings". RATIONALE: Gathering information about metabolic syndrome from young patients who have survived acute lymphoblastic leukemia (ALL) may help doctors learn more about the disease. PURPOSE: This phase I trial is studying the metabolic syndrome in young patients who have survived acute lymphoblastic le...
What is the current status of trial NCT00897078?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2009-01. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00897078?
The interventions under investigation include: laboratory biomarker analysis (OTHER), medical chart review (OTHER), questionnaire administration (OTHER), assessment of therapy complications (PROCEDURE), metabolic assessment (OTHER).
Who is sponsoring clinical trial NCT00897078?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.